Hi-Tech Fertility Products Analysis

Part
01
of five
Part
01

Hi-Tech Fertility Products Analysis - Mira Fertility Tracking Monitor

The Mira Fertility Tracking Monitor is fairly new technology, and therefore most specific financial information is not publically available. Information regarding the company's beginnings, current value, and companies with similar devices was available.

Mira Beginnings

  • The Mira Fertility Tracking Monitor, part of the fertility tracking system, was launched in 2018.
  • Mira Fertility Tracker allows hormone concentration tracking and prediction, get insights into the user's menstrual cycle, and provides health information. The full kit has a wand and analyzer, which is used to test urine for detailed hormone analysis.
  • The company was a startup project with OBGYNs, engineers, scientists, and business executives.
  • Mira was awarded "Best Startup of CES 2018".
  • The company raised $4.3M in funding prior to launch. The current company value is reported to be $4.5M.
  • Two investors were the primary funding sources — Gopher Ventures and Launchpad Digital Health.
  • The company was called Quanovate prior to changing the name to Mira in 2018.

Mira Connections

  • The Mira Fertility Tracker is part of the Ovusense platform.
  • Ovusense received $2.7M in funding by the end of 2019 for the digital platform to be commercialized.
  • Ovusense was founded in 2005 and has a reported value of 6.7M pounds, which is $8.7M.

Similar Fertility Apps

  • Glow is a fertility app founded in 2013. This app contains fertility tracking, health insights, health logs, and methods to connect with a partner in the family planning journey.
  • Glow raised $23M prior to launch the application, with 7 total investors.
  • The Clue fertility app launched in 2012. Clue allows women to keep track of their menstrual cycles and provides education on family planning, health, and sexual issues,
  • Clue began with a funding amount of $29.7M with 19 investors.
  • Kindara is a women's health and fertility app that launched in 2010. This app tracks and predicts the menstrual cycle, allows customized tracking, and connects women in a support community.
  • Kindara's funding is reported at $8.4M with 17 investors.

Research Strategy

Specific information on Mira Fertility Tracker's financial journey, such as the break-even point or revenue growth, was not located after an exhaustive search. The company is less than 2 years old, which may be a factor in the lack of information. Attempts were made to locate the requested information under Mira's original company name, Quanovate, but all sources linked back to the original information found for Mira. Searching similar fertility apps also resulted in limited information regarding current revenue and financial statistics over time. The initial funding and startup information for Mira was located, including the estimated current value of the company and investor listing. Additionally, funding and investor information for similar fertility apps was identified for comparison data points, as these apps have been in use longer than the Mira Fertility Tracker.
Part
02
of five
Part
02

Hi-Tech Fertility Products Analysis - Femometer Vinca Basal Thermometer for Ovulation

After an exhaustive search through credible sources, it appears that there is insufficient information available in the public domain to determine the break-even month and first month of profitability for Femometer Vinca Basal Thermometer for Ovulation.

Helpful Findings

  • The Femometer Vinca Basal Thermometer was launched on November 11, 2015. It was developed by Bongmi, a China-based mobile internet business that focuses on women and children's digital health. Founded in the year 2014, the company's very first product release was the Femometer, according to a press release that accompanied the smart fertility tracker's launch.
  • The first shipment for the Femometer Vinca Basal Thermometer occurred in March 2016.
  • On December 1, 2015, less than a month after its official launch, the product's developer (Bongmi) received approximately $1.57 million in total funding during its seed round. Its four investors included the Hangzhou Bsoft Company, Linear Venture, Lou Ting, and Xia Chen.
  • According to a March 2016 press release from Bongmi, the Femometer was around 240% funded by the conclusion of an Indiegogo campaign that coincided the product's release. Bongmi claims that this figure represented a remarkable demand for fertility-tracking apparatuses.
  • In total, the product's Indiegogo campaign helped to raise $92,730 from about 1,214 different backers.
  • There are two basal thermometers available from Femometer, namely the Femometer Vinca ($29.99) and the Femometer Vinca II ($49.99), along with an ovulation tracker designed for hormone testing, the Femometer Ivy ($59.99).

Research Strategy

During our research, we were unable to determine either the break-even month or the first month of profitability for Femometer Vinca Basal Thermometer for Ovulation. The primary reason for the lack of data is that Bongmi, which maintains ownership over the product and is its developer, operates as a private entity and has not released relevant details surrounding this topic to the public. Below is an overview of the research strategies we employed while searching for this information.

Our research began by searching for reports issued by Femometer surrounding the specified smart fertility tracker. For this information, we scanned through its official website, particularly the blog and press release sections. We implemented this research strategy because we believed that we could locate a comprehensive report created by Femometer's team that would contain useful insights on the financial details for Femometer Vinca Basal Thermometer. However, the website did not contain such a report, nor did its press release or blog sections offer any details that could help us triangulate the requested data (e.g., total amount spent on product, sales/revenue, profits, etc). We only found an overview of the product, prices, advice/recommendations, and other unrelated data.

Next, we searched for reports and articles from news and media sources profiling the Femometer Vinca Basal Thermometer, as well as industry and market research reports, to see if they mentioned any data points that could be used to determine the break-even month and first month of profitability. These sources included Market Wired, The Guardian, WIRED, Bloomberg, New York Magazine, among others. This research strategy was not fruitful as we found limited reporting on the product, and none of the sources produced useful results. Nevertheless, we discovered the company that helped develop the product, Bongmi.

With this information, we decided to investigate the official website of Bongmi, including its press release and blog sections, to see if they discussed the product's development and the financial details connected to it. Though we discovered the launch date of the product and the fact that it was 240% funded by the end of an Indiegogo campaign associated with it, there was no useful information available to determine its break-even month or first month of profitability. Also, we searched for any available company, financial, annual, or investor reports from Bongmi in the public domain, but only came across a test report (for the Femometer) that was posted by the FCC and did not contain any relevant data points.

Additionally, we came across Bongmi's Pitchbook profile that stated that the company is privately held, which explains the lack of publicly available data. We found a list of its executive team and decided to explore for interviews or reports featuring them, hoping to see if they discussed the break-even month and first month of profitability for the Femometer Vinca Basal Thermometer. Its executive team consists of Xiaoxia Ma (COO), Zesheng Wu (CTO and co-founder), Xiaodu Lou (CEO, co-founder, chairman, general manger), and Snow Li (PR manager, co-founder). Nonetheless, none of the interviews or reports featuring the executive team we came across offered any data points we could use to determine the requested information.
Part
03
of five
Part
03

Hi-Tech Fertility Products Analysis - Ovacue Fertility Monitor

The first OvaCue Fertility Monitor was introduced 25 years ago and is still being produced today. Information on the break-even month and the first month of profitability for the OvaCue Fertility Monitor is not publicly available.

Helpful Findings

  • Fairhaven Health is a key player in the global fertility test market. The entire fertility test market is projected to reach US$237.1 million by 2025.
  • OvaCue fertility monitoring devices were introduced to the market over 25 years ago. The OvaCue has undergone several improvements and model upgrades over the years. As of present, the OvaCue fertility kit consists of a hand-held monitor, an oral sensor, and a vaginal sensor that is capable of predicting ovulation several days in advance. It works by detecting the level of electrolyte present in the female body and claims an accuracy of 98.3%.
  • In 2018, Fairhaven Health was awarded a medical grant for the development of Sage Gel, a vaginal moisturizer designed to help improve the health of women.

Research Strategy

To determine the break-even month and the first month of profitability for the OvaCue Fertility Monitor, we first reviewed the company's websites, official publications, and other third-party business and health-related publications, such as Bloomberg, Forbes, and WebMD. This approach proved abortive, and we were unable to identify any publicly available information relating to the financials of the OvaCue Fertility Monitor or those of its manufacturer, Fairhaven Health. However, we found that the company operates as a private entity and is therefore not legally obliged to publicly release business information relating to its sales, profit, capital, market share, or investors.

Due to the lack of publicly available financials such as its revenue, growth, or profit margin, we could not estimate its break-even point or first month of profitability. We then decided to identify qualitative information such as quotes, chats, or interviews from its senior management team, such as its CEO and other senior sales executives. By utilizing this approach, we hoped to identify public comments from the company regarding the sales or profitability of the OvaCue Fertility Monitor which could tell us if or when the product broke even or attained profitability status. This approach also proved futile as none of the interviews or comments we identified contained any such information.

We were unable to find any credible source that details the break-even month or the first month of profitability for the OvaCue Fertility Monitor as it appeared to be unavailable after an exhaustive search of paywalled and free industry reports. The following paywalled reports may have more useful information:
Part
04
of five
Part
04

Hi-Tech Fertility Products Analysis - Lady Comp Fertility Computer

Information on the break-even month, as well as the first month of profitability for Lady Comp Fertility Computer is not publicly available. Lady Comp Fertility Computer is manufactured by Valley Electronics GmbH. It was first sold in Germany in 1986 and it is now sold in 35 countries.
  • Valley Electronics GmbH is a German company founded in 1986. It is the manufacturer of Lady Comp Fertility Computer.
  • While Valley Electronics says that it has been manufacturing Lady Comp since 1986, media reports show that the product was introduced to the U.S. and UK markets in 2004.
  • In 2004, then Managing Director of Valley Electronics said that Lady Comp had been "slow to take off in the UK" because the pill was widely available and there was little emphasis on natural
  • Crunchbase reports that Valley Electronics raised CHF1.5 million ($1.6 million) in funding from a Venture Round — Series Unknown on Jan 5, 2013.
  • RocketReach estimates that Valley Electronics rakes in about $3.8 million in annual revenue. It is sold in 35 countries.

RESEARCH STRATEGY

The information regarding the break-even month, as well as the first month of profitability for Lady Comp Fertility Computer is not publicly available. Our research entailed searching through the public domain for media reports or sentiments from the company's executives. We also searched through the company's website and social networks for any relevant information or communications from press releases. However, the company does not release any press releases and its website and social networks do not reveal anything other than the company's offerings. We also checked third-party sites such as Crunchbase but we could only find data on its parent company's funding round.
Part
05
of five
Part
05

Hi-Tech Fertility Products Analysis - ClearBlue Fertility Monitor

The Clearblue Fertility Monitor is a product of Swiss Precision Diagnostics GmbH, a privately held company founded in 2007. Thorough searches of publicly available information did not reveal enough data points to help us find or triangulate the product or company's break-even month or first month of profitability.

Company Details

Research Strategy

We searched thoroughly within the Clearblue product website, the company's website, company profile databases such as Crunchbase and Bloomberg, news reports, press releases, and other publicly available data for Clearblue Fertility Monitor's break-even month or the first month of profitability. We also attempted to look through academic papers or journals to look for case studies of the company or product that might reveal this information. We were unable to find profit information for the company Swiss Precision Diagnostics GmbH, or for the product Clearblue Fertility Monitor. Because of the lack of publicly available financial data, we were also unable to find financial data points that could help us triangulate the break-even month or the first month of profitability. The lack of publicly available data is likely due to Swiss Precision Diagnostics GmbH being a privately held company that is not obligated to publish annual reports publicly.



Sources
Sources

From Part 03